Panic and Depression After Lyme Disease

Psychiatric symptoms after Lyme treatment can include panic attacks, depression, cognitive slowing, and prominent somatic complaints. These presentations create diagnostic and therapeutic challenges because psychiatric, neurologic, autonomic, and post-infectious mechanisms may overlap.

In a published case report, Garakani and Mitton describe new-onset panic and depressive symptoms in a patient with a prior history of Lyme disease. The case illustrates how diagnostic framing and reassessment can influence outcomes.

Case Summary

A 37-year-old employed man presented with new-onset panic attacks, depression with suicidal thoughts, and multiple somatic complaints. Symptoms included palpitations, tremulousness, chest pressure, choking sensations, and an intense fear of dying.

He also reported back pain and muscle spasms, weakness and tingling in the extremities, generalized fatigue, poor sleep, low energy, diminished appetite, loss of interest in work and social activities, and a 10-pound weight loss. Despite two months of antidepressant and anxiolytic therapy, symptoms persisted.

Two years earlier, he described a tick exposure followed by fatigue, tinnitus, headaches, fever, and flu-like symptoms. Lyme ELISA was reported positive and he was treated with a three-week course of doxycycline. Acute symptoms improved, but anxiety and neuromuscular pain persisted, prompting repeated urgent visits.

Hospitalization, Persistent Symptoms, and Diagnostic Closure

He was admitted to inpatient psychiatry for depression and suicidal ideation and treated with antidepressants, anxiolytics, and a beta-blocker. Mood improved, but he continued to report cramping, flank pain, fatigue, arthritic knee pain, anxiety, impaired attention, cognitive slowing, and panic symptoms.

He reported being “very forgetful,” misplacing items and struggling to track medications. He expressed frustration and hopelessness in the setting of persistent cognitive and somatic symptoms.

After discharge, he continued to experience fatigue, weakness, spasms, shooting pains, and ascending paresthesias. Despite evaluation by multiple internists and neurologists—including negative Lyme Western blot testing—his symptoms persisted.

Clinical note: Suicidal ideation warrants urgent psychiatric evaluation regardless of suspected medical contributors. Infectious or inflammatory evaluation, when appropriate, should proceed in parallel with psychiatric care—not as a substitute for it. This “either/or” framing is a recurring issue in complex cases and overlaps with themes discussed in medical dismissal in Lyme disease.

Reassessment and Co-infection Considerations

Later testing reportedly demonstrated reactivity to Borrelia bands (31 and 34) and evidence of Babesia infection—findings that are not part of CDC surveillance criteria as commonly applied in routine practice.

He then received extended antimicrobial therapy (tetracycline followed by azithromycin and fluconazole as reported). After treatment, his panic attacks resolved, cognitive deficits improved, and depressive symptoms diminished sufficiently to discontinue psychiatric medications. Physical symptoms (fatigue, weakness, low energy, musculoskeletal pain) persisted and he remained unable to return to work.

This outcome does not establish a single mechanism for all patients. However, it highlights why co-infections and broader differential diagnosis may merit consideration in select patients with persistent neuropsychiatric symptoms following Lyme disease—especially when symptoms evolve or do not respond to standard psychiatric treatment alone.

Clinical Considerations Raised by the Case

Garakani and Mitton emphasize cognitive behavioral therapy (CBT) for mood symptoms in chronic illness. CBT can be appropriate and beneficial. The case also raises additional questions relevant to clinicians:

When should clinicians reconsider infectious, inflammatory, or autonomic contributors in persistent or atypical neuropsychiatric presentations?
How should testing limitations be weighed when symptoms are multisystem and evolving?
When co-infections are possible, what is an appropriate evaluation strategy?

These questions align with the broader systems problem of complex illness discussed in Why Lyme Disease Tests the Limits of Medicine.

Mechanisms That Can Mimic or Amplify Psychiatric Symptoms

Persistent neuropsychiatric symptoms may involve overlapping contributors such as immune-mediated changes, neuroinflammation, sleep disruption, autonomic instability, and post-infectious dysregulation. This broader framework is explored in Persistent Lyme Disease Mechanisms.

Autonomic symptoms—such as palpitations, lightheadedness, and physiologic “surges”—can resemble panic and may amplify anxiety. See Autonomic Dysfunction in Lyme Disease for related patterns.

Clinical Perspective

In practice, patients may present with panic, depression, cognitive difficulties, and unexplained physical symptoms after being told Lyme disease has been “resolved.” Some are referred exclusively to psychiatry without reassessment of possible infectious, co-infectious, inflammatory, autonomic, or other medical contributors.

Psychiatric care can be essential, particularly when suicidality is present. At the same time, when history and symptom patterns warrant it, medical reassessment may help avoid premature diagnostic closure and support a more complete evaluation.

Frequently Asked Questions

Can psychiatric symptoms appear years after Lyme treatment?
Yes. Some patients report new or persistent panic, depression, cognitive symptoms, and somatic complaints after prior Lyme disease. As with any psychiatric presentation, a careful differential diagnosis is essential.

Should psychiatric symptoms exclude further medical evaluation?
No. Psychiatric care and medical evaluation can proceed in parallel when clinical context supports reassessment.

Do co-infections matter in neuropsychiatric presentations?
They can. Co-infections such as Babesia or Bartonella may complicate symptom patterns and should be considered in select persistent or multisystem cases.

Is CBT sufficient on its own?
CBT can help with coping and mood symptoms. When symptoms are driven by physiologic mechanisms, CBT may be best used as a complement to appropriate medical evaluation and treatment planning.